ArticleJournal of clinical medicine2019

Switching between Three Types of Mesalazine Formulation and Sulfasalazine in Patients with Active Ulcerative Colitis Who Have Already Received High-Dose Treatment with These Agents.

Eriko Yasutomi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.